Skip to main content

T. Rowe Price Investment Management, Inc.

Position in BIIB — Biogen Inc.

CIK 1897612 BALTIMORE, MD

Position in BIIB

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$212,844,113
+$6,776,191 QoQ
Shares Held
1,160,989
-0.8% QoQ
Ownership
0.786%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 99.72480359417703.ToString("F0")% Shared 0.ToString("F0")% None 0.27519640582296645.ToString("F0")%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $1,197,745,873 across 8 Drug Manufacturers - General names. BIIB ranks #2 (17.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BIIB
Biogen Inc.
This page
1,160,989 $212,844,113

All Filings in BIIB

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $212,844,113 1,160,989
2025-12-31 $206,067,922 1,170,907
2025-09-30 $149,532,878 1,067,482
2025-06-30 $175,132,240 1,394,476
2025-03-31 $364,034,083 2,660,290
2024-12-31 $474,019,275 3,099,786
2024-09-30 $825,038,478 4,256,286
2024-06-30 $1,316,473,093 5,678,859
2024-03-31 $1,114,800,631 5,169,970
2023-12-31 $1,386,315,249 5,357,326
2023-09-30 $1,222,080,236 4,754,991
2023-06-30 $968,225,089 3,399,070